RT Journal Article
SR Electronic
T1 Assessing the Impact of Area Deprivation Index on COVID-19 Prevalence: A Contrast Between Rural and Urban U.S. Jurisdictions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.07.20208462
DO 10.1101/2020.10.07.20208462
A1 Christopher Kitchen
A1 Elham Hatef
A1 Hsien-Yen Chang
A1 Jonathan Weiner
A1 Hadi Kharrazi
YR 2020
UL http://medrxiv.org/content/early/2020/10/11/2020.10.07.20208462.abstract
AB Background The COVID-19 pandemic has impacted communities differentially, with poorer and minority populations being more adversely affected. Prior rural health research suggests such disparities may be exacerbated during the pandemic and in remote parts of the U.S.Objectives To understand the spread and impact of COVID-19 across the U.S., county level data for confirmed cases of COVID-19 were examined by Area Deprivation Index (ADI) scores and Metropolitan vs. Nonmetropolitan designations from the National Center for Health Statistics (NCHS). These designations were the basis for making comparisons between Urban and Rural jurisdictions.Methods Kendall’s Tau-B was used to compare effect sizes between jurisdictions on select ADI composites and well researched social determinants of health (SDH). Spearman coefficients and a moderation analysis using Poisson modeling was used to explore the relationship between ADI and COVID-19 prevalence in the context of county designation.Results Results show that the relationship between area deprivation and COVID-19 prevalence was positive and higher for rural counties, when compared to urban ones and that family income and poverty had a stronger relationship with prevalence than other ADI component measures.Conclusions Though most Americans live in Metropolitan Areas, rural communities were found to be associated with a stronger relationship between deprivation and COVID-19 prevalence. Models for predicting COVID-19 prevalence by ADI and county type reinforced this observation but revealed no moderating effect of county type on ADI.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo award or payment was given to any party involved in the production of this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This analysis makes use of publicly available data and was exempt from IRB review at Johns Hopkins University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the development of this manuscript were derived from publicly available files through the JHU CSSE Coronavirus tracking project and The U.S. Census Bureau's ACS.